Regulation of COVID-19 Medical Products Infographic

COVID-19 has triggered an urgent need for new medical products, including vaccines, medicines, diagnostics, personal protective equipment (PPE), and other medical devices such as those that deliver oxygen. As researchers rush to develop these products and clinicians plan for their delivery and safe use, national regulatory authorities play an essential public health role in ensuring that these products are safe, effective, quality-assured and affordable, and accessible to those in need in a timely manner. The USAID MTaPS Program is harnessing its regulatory systems strengthening expertise to support low- and middle-income countries in ensuring that COVID-19 medical products meet regulatory standards and save lives as intended.

The infographic below highlights vital regulatory functions needed to ensure safe, effective, and quality-assured COVID-19 medical products in LMICs and beyond.


Access this resource on its home site
[note that a new tab will open in your browser]


Leave a Reply

Click here to browse all resources, or find a resource using the search tool on this page.